Machine Learning

A strategic investment from FreeMind Investments and Daewoong Pharma validates General Proximity's novel platform for next-gen induced proximity medicines.

A new precision timing chip from SiTime promises to unlock massive GPU potential in AI data centers, tackling a costly inefficiency holding back AI.

A new intraoperative MRI gives surgeons real-time vision, promising more precise and safer glioma removal as it moves toward the competitive U.S. market.

Morningstar's investment chief joins a health AI firm, signaling a new era where financial modeling principles could unlock preventative wellness for millions.

The Boston-based startup's Bronze Stevie Award for AI Company of the Year validates its patented approach to automating tedious real estate invoice coding.

A new patent for a compact quantum atomic clock could revolutionize navigation and defense, placing Quantum X Labs in a high-stakes race for GPS independence.

With 14 years of losses and soaring claims, the commercial auto market is in peril. A new report reveals how AI and data are fighting back.

The new Gibco CTS DynaXS bioreactor aims to unlock scalable production, making life-saving cell therapies more accessible and affordable for patients.

Scott Drennan takes the helm at Otto Aerospace, tasked with turning the visionary, ultra-efficient Phantom 3500 jet from concept to certified reality.

A German biotech's novel in vivo CAR T platform uses DNA for durable tumor control, aiming to make advanced cancer therapy an off-the-shelf medicine.

A new testing platform from Armatus Bio aims to break a major bottleneck in gene therapy, promising faster paths to cures for rare neuromuscular diseases.

A new report shows CMOs wield unprecedented influence and AI, yet a majority feel their role is structurally flawed, hindering their path to success.

A new anechoic chamber in Syracuse allows Hidden Level to fast-track advanced RF systems, bolstering U.S. defenses against growing unmanned aerial threats.

The clinical-stage biotech adds seasoned veterans from Eli Lilly and Iovance to accelerate its promising DNA Damage Response pipeline toward commercialization.

Valitor's VLTR-559 shows superior durability in preclinical data, potentially slashing wet AMD treatment from monthly injections to just two per year.

A landmark partnership between Propella Group and TISTR aims to unlock Thailand's hidden scientific gems, creating a pipeline for global VCs.

A Miami firm's AI can make anchors speak any language in their own voice, promising a new era for global media. But what is the cost of this innovation?

Insurtech "centaur" Reserv Inc. secures massive funding to scale its AI-native claims platform, aiming to automate 30 million claims annually.

XPRIZE's new report reveals a $31B impact, proving its model creates lasting ventures and market disruption long after competitions end.

GRIN Therapeutics expands its pivotal Phase 3 study for radiprodil to Europe, fueling hope for a first-ever targeted therapy for a rare neurological disorder.